Clinical Trials Browser

Phase 1/2 × INDUSTRY × Fluorodeoxyglucose F18 × Clear all

NCT00453362 2017-03-31

A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib

Phase 1/2 Completed

88 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung